Skip to main content

Table 3 Clinical characteristics of patients in blood analysis

From: Overweight with HBV infection limited the efficacy of TACE in hepatocellular carcinoma by inhibiting the upregulated HMGB1

Parameters

Group 1a

(n = 4)

Group 2b

(n = 18)

Group 3c

(n = 6)

Group 4d

(n = 5)

Age (mean ± SD)

58.75 ± 12.12

61.05 ± 6.33

55.5 ± 6.16

60 ± 6.36

Sex

 Male

3

14

4

3

 Female

1

4

2

2

PVTTe

 Yes

0

6

2

1

 No

4

12

4

4

BCLCf

 A

2

5

2

1

 B

2

11

3

3

 C

0

2

1

1

Child–Pugh

 A

1

4

1

2

 B

3

13

5

3

 C

0

1

0

0

Milan criteria

 Yes

1

2

1

1

 No

3

16

5

4

Total tumor diameter (mm)

  < 30

1

3

1

0

 30–50

2

2

3

4

  > 50

1

13

2

1

Number of lesions

 1

4

17

5

4

 2

0

1

1

1

  ≥ 3

0

0

0

0

  1. aGroup 1: normal-weight patients without HBV
  2. bGroup 2: normal-weight patients combined HBV
  3. cGroup 3: overweight patients without HBV
  4. dGroup 4: overweight patients combined HBV
  5. ePVTT Portal vein tumor thrombus
  6. fBCLC Barcelona Clinic Liver Cancer